Delivery Order SPE2DR25D1004-SPE2DR26FSUS0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count units) with a ceiling value of $16,639.53. This firm fixed-price delivery order was issued on November 7, 2025, with an ultimate completion date of November 10, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Veozah 45 mg tablets (30-count units) with a ceiling value of $11,894.89. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $16,687.51 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count units) on November 7, 2025, with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $1,470.52 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-unit supply), with an ultimate completion date of July 25, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,976.56 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count) on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,541.30 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-unit package) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitive award utilized firm fixed pricing with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,432.43 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count packaging) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,414.80 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count packages). This firm fixed-price, non-set-aside delivery order was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is issued under a larger indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,502.99 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count packages) on September 9, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value transaction typical of the agency's pharmaceutical procurement operations. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,066.11 to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Veozah 45 mg tablets (30-unit package). This non-competitive, firm fixed-price delivery order is set to be completed by October 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement to support federal medical supply needs within the Defense...
- SPE2DR25D1004Indefinite Delivery Contract
- SPE2DR25D1004-SPE2DR26FSUS0Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,746.14 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count packaging) with a completion date of November 10, 2025. This non-competitive, firm fixed-price delivery order was issued on November 7, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is well-positioned to fulfill this requirement as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. AmerisourceBergen Drug Corp's extensive portfolio of federal awards and demonstrated capability to compete for pharmaceutical supply contracts make it a significant provider within DLA's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 11/7/25 |